Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach +++ Authors: François-Clément Bidard, MD, PhD; Nicola Fusco, MD, PhD

https://www.medscape.org/viewarticle/1002782?sso=true&uac=148436CN&mkmcmr_driv_cust_mscpedu_251016-OUS-Honc-1002782-cta= Hormone Receptor-Positive Metastatic Breast Cancer: Novel Endocrine-Based Strategies and Options After Progression ++ Authors: Volkmar Müller, MD; Erica L. Mayer, MD, MPH https://www.medscape.org/viewarticle/1002835?mkmcmr_driv_cust_mscpedu_251016-OUS-Honc-1002835-cta=&uac=148436CN&sso=true Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer +++ Authors: Judy King, MRCP, PhD; Giuseppe Curigliano, MD, PhD; Peter Schmid, MD, PhD, FRCP https://www.medscape.org/viewarticle/1002851?mkmcmr_driv_cust_mscpedu_251016-OUS-Honc-1002851-cta=&uac=148436CN&sso=true